Related Experiment Video
Updated: Jan 13, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Integrated Network Pharmacology and Molecular Dynamics Reveal Multi-Target Anticancer Mechanisms of Myrtus communis
Ahmed Bayoudh1, Nidhal Tarhouni1, Riadh Ben Mansour2
1Laboratory of Enzyme Engineering and Microbiology, Engineering National School of Sfax (ENIS), University of Sfax, P.O. Box 1173, Sfax 3038, Tunisia.
Abstract:
Background: Cancer's multifactorial complexity demands innovative polypharmacological strategies that can simultaneously target multiple oncogenic pathways. Natural products, with their inherent chemical diversity, offer promising multi-target therapeutic potential. This study comprehensively investigates the anticancer mechanisms of Tunisian Myrtus communis essential oils (McEOs) using an integrated computational-experimental framework to elucidate their polypharmacological basis and therapeutic potential. Methods: McEO composition was characterized via GC-MS analysis. Antiproliferative activity was evaluated against HeLa (cervical), MCF-7 (breast), and Raji (lymphoma) cancer cell lines using MTT assays. A multi-scale computational pipeline integrated network pharmacology, molecular docking against eight key oncoproteins, and 100 ns all-atom molecular dynamics simulations to elucidate molecular mechanisms and target interactions. Results: GC-MS revealed a 1,8-cineole-rich chemotype (38.94%) containing significant sesquiterpenes. McEO demonstrated potent differential cytotoxicity: HeLa (IC50 = 8.12 μg/mL) > MCF-7 (IC50 = 19.59 μg/mL) > Raji cells (IC50 = 27.32 μg/mL). Network pharmacology quantitatively explained this differential sensitivity through target overlap analysis, showing higher associations with breast (23%) and cervical (18.3%) versus lymphoma (5.5%) cancer pathways. Molecular docking identified spathulenol as a high-affinity Androgen Receptor (AR) antagonist (XP GScore: -9.650 kcal/mol). Molecular dynamics simulations confirmed exceptional spathulenol-AR complex stability, maintaining critical hydrogen bonding with Asn705 for 96% of simulation time. Conclusions: McEO exerts sophisticated multi-target anticancer effects through synergistic constituent interactions, notably spathulenol's potent AR antagonism. This integrated computational-experimental approach validates McEO's polypharmacological basis and supports its therapeutic potential, particularly for hormone-dependent malignancies, while establishing a robust framework for natural product bioactivity deconvolution.
Insights
Tunisian Myrtus communis essential oils (McEOs) show potent anticancer activity by targeting multiple pathways, with spathulenol acting as a strong Androgen Receptor antagonist, supporting potential for hormone-dependent cancers.
Area of Science:
- Natural Product Chemistry
- Computational Biology
- Pharmacology
Background:
- Cancer complexity necessitates polypharmacological strategies targeting multiple oncogenic pathways.
- Natural products offer diverse chemical structures for multi-target drug discovery.
- Myrtus communis essential oils (McEOs) possess potential for anticancer applications.
Purpose of the Study:
- Investigate the anticancer mechanisms of Tunisian McEOs.
- Elucidate the polypharmacological basis and therapeutic potential of McEOs.
- Utilize an integrated computational-experimental framework.
Main Methods:
- Gas Chromatography-Mass Spectrometry (GC-MS) for McEO composition analysis.
- MTT assays for antiproliferative activity against HeLa, MCF-7, and Raji cancer cell lines.
- Network pharmacology, molecular docking, and molecular dynamics simulations for mechanism elucidation.
Main Results:
- McEOs are rich in 1,8-cineole and sesquiterpenes.
- Demonstrated differential cytotoxicity: HeLa > MCF-7 > Raji.
- Identified spathulenol as a high-affinity Androgen Receptor antagonist.
- Confirmed spathulenol-AR complex stability via molecular dynamics.
Conclusions:
- McEOs exert multi-target anticancer effects through synergistic interactions.
- Spathulenol's potent Androgen Receptor antagonism contributes significantly to McEOs' activity.
- Validated McEOs' therapeutic potential for hormone-dependent malignancies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules
